Molly Henderson
CIK 1363812 · CFO and CBO · last filed 2025-04-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PHAT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
PRINCETON, NJ 08540
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHAT | CFO and CBO | 91,779 | $6.06 | $556.2K | -$447.0K | 22 | 2025-04-08 |
| URGN | Chief Financial Officer | 5,579 | $34.10 | $190.2K | $6.0K | 6 | 2022-02-02 |
| Ayala Pharmaceuticals, Inc. (ADXS) Delisted | Executive Vice President & CFO | 73 | $0.60 | $44 | $0 | 5 | 2020-05-05 |
| Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Executive Vice President & CFO | 5,000 | — | — | $0 | 2 | 2018-06-13 |
| IOVANCE BIOTHERAPEUTICS, INC. (LBIO) Delisted | CFO | — | — | — | $0 | 4 | 2016-06-15 |
| VirtualScopics, Inc. (VSCP) Delisted | Chief Business/Financial Off. | 1,440 | — | — | $11.6K | 12 | 2013-02-11 |
Recent Filings · Page 5 of 6
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-06-21 | VirtualScopics, Inc. (VSCP) Delisted | Buy (P) | +8,000 | $7.2K | EDGAR |
| 2012-01-30 | VirtualScopics, Inc. (VSCP) Delisted | O | — | $0 | EDGAR |
| 2011-03-04 | VirtualScopics, Inc. (VSCP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-03-15 | VirtualScopics, Inc. (VSCP) Delisted | Buy (P) | — | $0 | EDGAR |
| 2010-02-12 | VirtualScopics, Inc. (VSCP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-11-06 | VirtualScopics, Inc. (VSCP) Delisted | Mixed | — | $0 | EDGAR |
| 2009-02-26 | VirtualScopics, Inc. (VSCP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-05-12 | VirtualScopics, Inc. (VSCP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-03-17 | VirtualScopics, Inc. (VSCP) Delisted | Buy (P) | +6,440 | $4.4K | EDGAR |
| 2008-02-28 | VirtualScopics, Inc. (VSCP) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.